VSEE
Get informed when a big investor buys or sells
+ FollowOvervalued by 111.3% based on the discounted cash flow analysis.
| Market cap | $1.41 Million |
|---|---|
| Enterprise Value | $2.84 Million |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $-58.4 |
| Beta | 0.51 |
| Outstanding Shares | 670,722 |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | 0.12 |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | 0.22 |
| Enterprise Value to EBIT | -0.53 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.66 |
| Debt to Equity | 0.25 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 12.38%▲ 3.12% |
|---|---|
| Total Invested | $767,821▼ 30.73% |
| Investors Holding | 19▲ 7.00% |
No data
VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to pati...